vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Palomar Holdings, Inc. (PLMR). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $253.4M, roughly 1.4× Palomar Holdings, Inc.). On growth, Palomar Holdings, Inc. posted the faster year-over-year revenue change (62.7% vs 9.4%). Palomar Holdings, Inc. produced more free cash flow last quarter ($409.0M vs $36.1M). Over the past eight quarters, Palomar Holdings, Inc.'s revenue compounded faster (46.2% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Palomar Holdings, Inc. is a specialty insurance holding company that primarily provides property insurance products for catastrophe-exposed residential and commercial assets. It mainly operates across the United States, focusing on core segments including earthquake, flood, and windstorm coverage to meet high-risk property protection demands of customers.
ASIX vs PLMR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $359.9M | $253.4M |
| Net Profit | $-2.8M | — |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | 28.7% |
| Net Margin | -0.8% | — |
| Revenue YoY | 9.4% | 62.7% |
| Net Profit YoY | -892.9% | — |
| EPS (diluted) | $-0.11 | $2.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $253.4M | ||
| Q3 25 | $374.5M | $244.7M | ||
| Q2 25 | $410.0M | $203.3M | ||
| Q1 25 | $377.8M | $174.6M | ||
| Q4 24 | $329.1M | $155.8M | ||
| Q3 24 | $398.2M | $148.5M | ||
| Q2 24 | $453.5M | $131.1M | ||
| Q1 24 | $336.8M | $118.5M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-2.6M | $51.5M | ||
| Q2 25 | $31.4M | $46.5M | ||
| Q1 25 | $23.3M | $42.9M | ||
| Q4 24 | $352.0K | — | ||
| Q3 24 | $22.3M | $30.5M | ||
| Q2 24 | $38.9M | $25.7M | ||
| Q1 24 | $-17.4M | $26.4M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | 28.7% | ||
| Q3 25 | -0.9% | 27.4% | ||
| Q2 25 | 7.7% | 29.5% | ||
| Q1 25 | 7.7% | 30.8% | ||
| Q4 24 | -3.9% | 28.9% | ||
| Q3 24 | 7.5% | 25.9% | ||
| Q2 24 | 11.5% | 25.5% | ||
| Q1 24 | -7.0% | 29.0% |
| Q4 25 | -0.8% | — | ||
| Q3 25 | -0.7% | 21.0% | ||
| Q2 25 | 7.7% | 22.9% | ||
| Q1 25 | 6.2% | 24.6% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.6% | 20.5% | ||
| Q2 24 | 8.6% | 19.6% | ||
| Q1 24 | -5.2% | 22.3% |
| Q4 25 | $-0.11 | $2.05 | ||
| Q3 25 | $-0.10 | $1.87 | ||
| Q2 25 | $1.15 | $1.68 | ||
| Q1 25 | $0.86 | $1.57 | ||
| Q4 24 | $0.02 | $1.29 | ||
| Q3 24 | $0.82 | $1.15 | ||
| Q2 24 | $1.43 | $1.00 | ||
| Q1 24 | $-0.65 | $1.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $106.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $942.7M |
| Total Assets | $1.7B | $3.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $106.9M | ||
| Q3 25 | $23.7M | $111.7M | ||
| Q2 25 | $18.4M | $81.3M | ||
| Q1 25 | $8.3M | $119.3M | ||
| Q4 24 | $19.6M | $80.4M | ||
| Q3 24 | $17.3M | $86.5M | ||
| Q2 24 | $12.1M | $47.8M | ||
| Q1 24 | $20.6M | $61.4M |
| Q4 25 | $815.2M | $942.7M | ||
| Q3 25 | $818.2M | $878.1M | ||
| Q2 25 | $823.7M | $847.2M | ||
| Q1 25 | $794.4M | $790.4M | ||
| Q4 24 | $774.6M | $729.0M | ||
| Q3 24 | $766.4M | $703.3M | ||
| Q2 24 | $746.6M | $532.6M | ||
| Q1 24 | $713.2M | $501.7M |
| Q4 25 | $1.7B | $3.1B | ||
| Q3 25 | $1.7B | $2.9B | ||
| Q2 25 | $1.6B | $2.8B | ||
| Q1 25 | $1.6B | $2.4B | ||
| Q4 24 | $1.6B | $2.3B | ||
| Q3 24 | $1.5B | $2.3B | ||
| Q2 24 | $1.5B | $2.0B | ||
| Q1 24 | $1.5B | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $409.1M |
| Free Cash FlowOCF − Capex | $36.1M | $409.0M |
| FCF MarginFCF / Revenue | 10.0% | 161.4% |
| Capex IntensityCapex / Revenue | 7.7% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $700.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $409.1M | ||
| Q3 25 | $26.6M | $83.6M | ||
| Q2 25 | $21.1M | $120.9M | ||
| Q1 25 | $11.4M | $87.2M | ||
| Q4 24 | $64.2M | $261.2M | ||
| Q3 24 | $57.3M | $100.3M | ||
| Q2 24 | $50.2M | $55.1M | ||
| Q1 24 | $-36.2M | $33.1M |
| Q4 25 | $36.1M | $409.0M | ||
| Q3 25 | $66.0K | $83.6M | ||
| Q2 25 | $-7.2M | $120.8M | ||
| Q1 25 | $-22.6M | $87.1M | ||
| Q4 24 | $29.8M | $260.9M | ||
| Q3 24 | $26.8M | $100.1M | ||
| Q2 24 | $16.7M | — | ||
| Q1 24 | $-71.6M | — |
| Q4 25 | 10.0% | 161.4% | ||
| Q3 25 | 0.0% | 34.2% | ||
| Q2 25 | -1.7% | 59.4% | ||
| Q1 25 | -6.0% | 49.9% | ||
| Q4 24 | 9.1% | 167.5% | ||
| Q3 24 | 6.7% | 67.4% | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | -21.3% | — |
| Q4 25 | 7.7% | 0.1% | ||
| Q3 25 | 7.1% | 0.0% | ||
| Q2 25 | 6.9% | 0.0% | ||
| Q1 25 | 9.0% | 0.0% | ||
| Q4 24 | 10.4% | 0.2% | ||
| Q3 24 | 7.7% | 0.1% | ||
| Q2 24 | 7.4% | 0.0% | ||
| Q1 24 | 10.5% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.63× | ||
| Q2 25 | 0.67× | 2.60× | ||
| Q1 25 | 0.49× | 2.03× | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | 3.29× | ||
| Q2 24 | 1.29× | 2.14× | ||
| Q1 24 | — | 1.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
PLMR
Segment breakdown not available.